Generic Betoptic

Of the two different forms of Betoptic (betaxolol), only one is available as a generic. Betoptic S is still under the protection of an exclusivity period until December 2010. However, a generic version of regular Betoptic is currently available and is sold by the name Betaxolol Hydrochloride 0.5 percent solution. This product is considered to be equivalent to the brand-name eye drop.

Is a Generic Version of Betoptic Available?

Betoptic® (betaxolol hydrochloride) is a prescription eye drop approved for the treatment of glaucoma and high eye pressure. Betoptic belongs to a group of medications known as beta blockers. This medicine comes in two different forms -- regular Betoptic (a solution) and Betoptic S® (a suspension). In a solution, the medication is dissolved in the liquid and does not need to be shaken; in a suspension, the medication is not dissolved and must be shaken well before each dose.
 
Brand-name Betoptic products are made by Alcon Laboratories. While regular Betoptic is available in generic form, there are no generic versions of Betoptic S at this time.
 

When Will Generic Betoptic S Be Available?

Although the patents for both Betoptic products have expired, the United States Food and Drug Administration (FDA) granted manufacturers of Betoptic S an additional exclusivity period (during which no generic versions are allowed) for performing much-needed studies of the medication in children. Currently, the exclusivity period for Betoptic S is set to expire in December 2010. At that time, generic versions may become available.
 

Availability of Regular Betoptic in Generic Form

Although Betoptic S suspension is not available in generic form, regular Betoptic solution is available as a generic (sold as "Betaxolol Hydrochloride 0.5 percent solution"). A few different companies make this generic version of Betoptic, including:
 
  • Akorn
  • Bausch & Lomb
  • Falcon Pharmaceuticals.
     
(Generic Betoptic Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation